Luminescences of the 2023 Bethesda System for Reporting Thyroid Cytopathology, 3rd edition, in Thyroidology

Year 2024, Volume: 1 Issue: 2, 72 - 74, 14.06.2024

Ilker Sengul Demet Sengul

Abstract

Mater artium necessitas. The Bethesda System for Reporting Thyroid Cytopathology (TBSRCT), per se, has still been crucial for Endocrine Pathologists, Endocrine Surgeons, Neck-Endocrine Surgeons, Endocrinologists, Head&Neck Surgeons, Laryngologists, Head&Neck Radiologists, Nuclear Medicine, and Thyroidologists, globally. The 2010 TBSRTC, 1st edition, was initially proposed in Bethesda, Maryland, USA, in 2007, providing Thyroidologists to utilize a standardized reporting system for thyroid fine-needle aspiration (FNA) [1]. The 2015 American Thyroid Association management guidelines have also endorsed wielding TBSRTC [2] through this delicate papillon endocrine gland [5-9]. Furthermore, a special 2½-hour symposium was moderated by Ali and Vielh at the 19th International Congress of Cytology, ICC, in Pacifico Yokohama, Japan on 28 May–01 June 2016 [10-12]. Subsequently, the 2017 TBSRTC, 2nd edition, was then published by amendment of indeterminate cytology [13].

Keywords

Thyroid gland, Thyroid nodule, Ultrasonography, Subcategorization, Subdivision, Bethesda, Endocrine Pathology, Endocrine Surgery, Thyroidology, Thyroidologists.

Ethical Statement

None declared.